The Global Tissue
Engineering Market, by Material Type (Synthetic, Biological, and Others),
by Application (Dermal, Orthopedic, Dental, Neurology, and Others), and by
Region (North America, Latin America, Europe, Asia Pacific, Middle East, and
Africa) was valued at US$ 5.5 billion in 2017, and is projected to exhibit a
CAGR of 11.5% over the forecast period (2018 - 2026).
Various diseases, injury, and
trauma can lead to degeneration and damage of tissues in the human body, which
necessitates treatments to enable repair, replacement or regeneration of
damaged tissue. The treatment normally focuses on transplanting tissue from one
site to another in the same patient (an autograft) or from one individual to
another (a transplant or allograft). Tissue engineering is an
inter-disciplinarily research area, which has wider applications in repair of
organs, regeneration, and tissue transplantation. The technology uses synthetic
or naturally derived, engineered biomaterials to replace defective or damaged
tissues, such as bone, skin, and organs. Key manufacturers in the tissue
engineering market are focused on mergers and acquisitions, and partnerships
with smaller companies.
* The sample copy includes:
Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report
Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/2217
For instance, in 2017, FUJIFILM
Corporation invested US$ 3.7 million in the regenerative medicine venture
company NC Medical Research, Inc. with NC Medical granting Fujifilm a stock
allocation. Rapid advances in stem cell research with a focus on therapeutic
potential for regenerative medicine and other biomedical applications are
expected to drive market growth. In combination with tissue engineering, stem
cells exhibit growth opportunities in further advancing modern medicine.
Although much progress has been made in the field of tissue engineering, further
research regarding organ and tissue replacement is necessary. The optimal cell
source, scaffold design, and in vitro bioreactors, the use and development of
microfabrication technology to create vascularized tissues and organs are still
being investigated.
Browse 21 Market Data Tables and
24 Figures spread through 175 Pages and in-depth TOC on "Tissue
Engineering Market, by Material Type (Synthetic, Biological and Others), by
Application (Dermal, Orthopedic, Dental, Neurology, and Others), and by Region
(North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -
Global Forecast to 2026"
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/tissue-engineering-market-2217
Key Takeaways of the Tissue
Engineering Market:
The global tissue engineering
market is expected to expand at a CAGR of 11.5% during the forecast period
(2018–2026), owing to increasing demand for organ transplantation.
Among region, Europe is expected
to grow at lucrative rate, owing to presence of various public and private
organizations focusing on research in tissue engineering field.
Major players operating in the
global tissue engineering market include Acelity L.P. Inc., Allergan Plc.,
Athersys, Inc., B. Braun, BioMimetic Therapeutics, Bio Tissue Technologies, C.
R. Bard, International Stem Cell, Integra Lifesciences, Medtronic, Inc.,
Organogenesis Inc., Osiris Therapeutics, RTI surgical, Inc., Stryker
Corporation, Tissue Regenix Group Plc., and Zimmer Biomet.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/2217
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
No comments:
Post a Comment